Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
Salmanpour
Rahmatolah
R
Razmavar
Mohammad Reza
MR
Abtahi
Noshin
N
D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017679:Cryotherapy / Q000379:methods*; D006801:Humans; D015552:Injections, Intralesional; D007492:Iran; D007891:Leishmania / Q000187:drug effects; D016773:Leishmaniasis, Cutaneous / Q000469:parasitology / Q000628:therapy*; D008536:Meglumine / Q000008:administration & dosage / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate